[(2R,3S,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-methoxy-5-[2-oxo-4-[2,4,6-tri(propan-2-yl)phenyl]sulfonyloxypyrimidin-1-yl]-2-[[(2,2,2-trifluoroacetyl)amino]methyl]oxolan-3-yl] acetate | 1391040-28-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 英文名称: [(2R,3S,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-methoxy-5-[2-oxo-4-[2,4,6-tri(propan-2-yl)phenyl]sulfonyloxypyrimidin-1-yl]-2-[[(2,2,2-trifluoroacetyl)amino]methyl]oxolan-3-yl] acetate
• CAS: 1391040-28-0
• 化学式: C₅₁H₅₈F₃N₃O₁₂S
• 分子量: 994.096
• InChiKey: MFKXIZMXKYXGLV-YOTISACQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.8
• 重原子数：
  70
• 可旋转键数：
  20
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  186
• 氢给体数：
  1
• 氢受体数：
  15

反应信息

• 作为反应物：
  描述：

  [(2R,3S,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-methoxy-5-[2-oxo-4-[2,4,6-tri(propan-2-yl)phenyl]sulfonyloxypyrimidin-1-yl]-2-[[(2,2,2-trifluoroacetyl)amino]methyl]oxolan-3-yl] acetate 在 氨 作用下， 以 四氢呋喃 、 水 为溶剂， 以31 mg的产率得到1-[2'-O-methyl-4'-C-trifluoroacetylaminomethyl-5'-(4,4'-dimethoxytrityl)-β-D-ribofuranosyl]cytosine
  参考文献：
  名称：

  Synthesis, Gene Silencing, and Molecular Modeling Studies of 4′-C-Aminomethyl-2′-O-methyl Modified Small Interfering RNAs

  摘要：

  The linear syntheses of 4'-C-aminomethyl-2'-O-methyl uridine and cytidine nucleoside phosphoramidites were achieved using glucose as the starting material. The modified RNA building blocks were incorporated into small interfering RNAs (siRNAs) by employing solid phase RNA synthesis. Thermal melting studies showed that the modified siRNA duplexes exhibited slightly lower T-m (similar to 1 degrees C/modification) compared to the unmodified duplex. Molecular dynamics simulations revealed that the 4'-C-aminomethyl-2'-O-methyl modified nucleotides adopt South-type conformation in a siRNA duplex, thereby altering the stacking and hydrogen-bonding interactions. These modified siRNAs were also evaluated for their gene silencing efficiency in HeLa cells using a luciferase-based reporter assay. The results indicate that the modifications are well tolerated in various positions of the passenger strand and at the 3' end of the guide strand but are less tolerated in the seed region of the guide strand. The modified siRNAs exhibited prolonged stability in human serum compared to unmodified siRNA. This work has implications for the use of 4'-C-aminomethyl-2'-O-methyl modified nucleotides to overcome some of the challenges associated with the therapeutic utilities of siRNAs.

  DOI：

  10.1021/jo202666m
• 作为产物：
  描述：

  1-(2'-O-methyl-3',5'-di-O-benzyl-4'-C-azidomethyl-β-D-ribofuranosyl)uracil 在 4-二甲氨基吡啶 、 palladium 10% on activated carbon 、 水 、 氢气 、 三乙胺 、 三苯基膦 作用下， 以 四氢呋喃 、 吡啶 、 乙醇 、 二氯甲烷 为溶剂， 反应 50.0h， 生成 [(2R,3S,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-methoxy-5-[2-oxo-4-[2,4,6-tri(propan-2-yl)phenyl]sulfonyloxypyrimidin-1-yl]-2-[[(2,2,2-trifluoroacetyl)amino]methyl]oxolan-3-yl] acetate
  参考文献：
  名称：

  Synthesis, Gene Silencing, and Molecular Modeling Studies of 4′-C-Aminomethyl-2′-O-methyl Modified Small Interfering RNAs

  摘要：

  The linear syntheses of 4'-C-aminomethyl-2'-O-methyl uridine and cytidine nucleoside phosphoramidites were achieved using glucose as the starting material. The modified RNA building blocks were incorporated into small interfering RNAs (siRNAs) by employing solid phase RNA synthesis. Thermal melting studies showed that the modified siRNA duplexes exhibited slightly lower T-m (similar to 1 degrees C/modification) compared to the unmodified duplex. Molecular dynamics simulations revealed that the 4'-C-aminomethyl-2'-O-methyl modified nucleotides adopt South-type conformation in a siRNA duplex, thereby altering the stacking and hydrogen-bonding interactions. These modified siRNAs were also evaluated for their gene silencing efficiency in HeLa cells using a luciferase-based reporter assay. The results indicate that the modifications are well tolerated in various positions of the passenger strand and at the 3' end of the guide strand but are less tolerated in the seed region of the guide strand. The modified siRNAs exhibited prolonged stability in human serum compared to unmodified siRNA. This work has implications for the use of 4'-C-aminomethyl-2'-O-methyl modified nucleotides to overcome some of the challenges associated with the therapeutic utilities of siRNAs.

  DOI：

  10.1021/jo202666m